OBJECTIVE: To assess the changes in quality of life, arrhythmia symptoms, and hospital resource utilisation following catheter ablation of typical atrial flutter. DESIGN: Patient questionnaire to compare the time interval following ablation with a similar time interval before ablation. SETTING: Tertiary referral centre. PATIENTS: 63 consecutive patients were studied. Four patients subsequently underwent an ablate and pace procedure, two died of co-morbid illnesses, and two were lost to follow up. The remaining 55 patients form the basis of the report. RESULTS: Patients were followed for a mean (SD) of 12 (9.5) months. Atrial flutter ablation resulted in an improvement in quality of life (3.8 v 2.5, p < 0.001) and reductions in symptom frequency score (2.0 v 3.5, p < 0.001) and symptom severity score (2.0 v 3.8, p < 0.001) compared with preablation values. There was a reduction in the number of patients visiting accident and emergency departments (11% v 53%, p < 0.001), requiring cardioversion (7% v 51%, p < 0.001), or being admitted to hospital for a rhythm problem (11% v 56%, p < 0.001). Subgroup analysis confirmed that patients with atrial flutter and concomitant atrial fibrillation before ablation and those with atrial flutter alone both derived significant benefit from atrial flutter ablation. Patients with concomitant atrial fibrillation had an improvement in quality of life (3.5 v 2.5, p < 0.001) and reductions in symptom frequency score (2.3 v 3.5, p < 0.001) and symptom severity score (2.2 v 3.7, p < 0.001) compared with preablation values. CONCLUSIONS: Ablation of atrial flutter is recommended both in patients with atrial flutter alone and in those with concomitant atrial fibrillation.
OBJECTIVE: To assess the changes in quality of life, arrhythmia symptoms, and hospital resource utilisation following catheter ablation of typical atrial flutter. DESIGN:Patient questionnaire to compare the time interval following ablation with a similar time interval before ablation. SETTING: Tertiary referral centre. PATIENTS: 63 consecutive patients were studied. Four patients subsequently underwent an ablate and pace procedure, two died of co-morbid illnesses, and two were lost to follow up. The remaining 55 patients form the basis of the report. RESULTS:Patients were followed for a mean (SD) of 12 (9.5) months. Atrial flutter ablation resulted in an improvement in quality of life (3.8 v 2.5, p < 0.001) and reductions in symptom frequency score (2.0 v 3.5, p < 0.001) and symptom severity score (2.0 v 3.8, p < 0.001) compared with preablation values. There was a reduction in the number of patients visiting accident and emergency departments (11% v 53%, p < 0.001), requiring cardioversion (7% v 51%, p < 0.001), or being admitted to hospital for a rhythm problem (11% v 56%, p < 0.001). Subgroup analysis confirmed that patients with atrial flutter and concomitant atrial fibrillation before ablation and those with atrial flutter alone both derived significant benefit from atrial flutter ablation. Patients with concomitant atrial fibrillation had an improvement in quality of life (3.5 v 2.5, p < 0.001) and reductions in symptom frequency score (2.3 v 3.5, p < 0.001) and symptom severity score (2.2 v 3.7, p < 0.001) compared with preablation values. CONCLUSIONS: Ablation of atrial flutter is recommended both in patients with atrial flutter alone and in those with concomitant atrial fibrillation.
Authors: C T Tai; S A Chen; C E Chiang; S H Lee; Z C Wen; J L Huang; Y J Chen; W C Yu; A N Feng; Y J Lin; Y A Ding; M S Chang Journal: J Cardiovasc Electrophysiol Date: 1998-02
Authors: Y Iesaka; A Takahashi; M Goya; T Yamane; T Tokunaga; H Amemiya; H Fujiwara; J Nitta; A Nogami; K Aonuma; M Hiroe; F Marumo; M Hiraoka Journal: Pacing Clin Electrophysiol Date: 1998-02 Impact factor: 1.976
Authors: Axel Meissner; Martin Christ; Petra Maagh; Rolf Borchard; Marc van Bracht; Ingo Wickenbrock; Hans-Joachim Trappe; Gunnar Plehn Journal: Clin Res Cardiol Date: 2007-08-31 Impact factor: 5.460
Authors: Axel Meissner; Irini Stifoudi; Peter Weismüller; Max-Olav Schrage; Petra Maagh; Martin Christ; Thomas Butz; Hans-Joachim Trappe; Gunnar Plehn Journal: Int J Med Sci Date: 2009-01-11 Impact factor: 3.738
Authors: Javier García Seara; Francisco Gude; Pilar Cabanas; José L Martínez-Sande; Xesús Fernández López; Antonio Hernández Madrid; Concepción Moro; José R González Juanatey Journal: Health Qual Life Outcomes Date: 2012-08-06 Impact factor: 3.186
Authors: A S Thornton; P Janse; M Alings; M F Scholten; J M Mekel; M Miltenburg; E Jessurun; L Jordaens Journal: J Interv Card Electrophysiol Date: 2008-03-25 Impact factor: 1.900
Authors: Pilar Cabanas-Grandío; Javier García-Seara; Francisco Gude; José Luis Martínez-Sande; Xesús Alberte Fernández-López; José R González-Juanatey Journal: Health Qual Life Outcomes Date: 2014-04-07 Impact factor: 3.186